Cabometyx Logo

This website is intended for healthcare professionals and for patients who have been prescribed Cabometyx® for advanced renal cell carcinoma (aRCC).

Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie. Adverse events should also be reported to the Ipsen Medical Information Department on +353 18098256 or pharmacovigilance.uk-ie@ipsen.com